Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,930.00
Bid: 1,920.00
Ask: 1,921.00
Change: 17.00 (0.89%)
Spread: 1.00 (0.052%)
Open: 1,921.00
High: 1,930.00
Low: 1,901.00
Prev. Close: 1,913.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks end lower; investors shun Deliveroo

Wed, 31st Mar 2021 17:04

(Alliance News) - Stocks in London ended the quarter mostly lower against a backdrop of rising coronavirus cases on the continent and interest rate fears in the US, while Deliveroo's high-profile stock market debut disappointed.

The FTSE 100 index closed down 58.49 points, or 0.9%, at 6,713.63. The FTSE 250 ended down 55.73 points, or 0.3%, at 21,518.71. The AIM All-Share closed up 3.70 points, or 0.3%, at 1,197.87.

The Cboe UK 100 ended down 0.8% at 670.90, the Cboe UK 250 closed down 0.1% at 19,266.45, and the Cboe Small Companies ended up 0.1% at 13,886.21.

In Paris the CAC 40 ended 0.3%, while the DAX 30 in Frankfurt ended flat.

"It's been a somewhat subdued end of the month and the quarter for European shares in today's session, as we look back on a quarter that has seen some fairly decent gains across the board, despite the various lockdowns and restrictions," said CMC Markets analyst Michael Hewson.

"The markets main focus has been directed towards the prospects for an economic reopening and while that prospect is much closer in the US and the UK, there is some anticipation that Europe will get there eventually, though that optimism could well dissipate if we don't get some progress on vaccinations, as well as evidence of a slowdown in infections," Hewson added.

In the FTSE 100, Scottish Mortgage Investment Trust ended the best performer, up 3.8%, tracking a rise in Tesla and Amazon, in which it owns shares. The trust has a 5.1% stake in Elon Musk's Tesla and a 5.9% holding in Jeff Bezos's Amazon. Shares in Tesla and Amazon were up 3.9% and 1.6% in New York respectively.

Hikma Pharmaceuticals closed up 3.5% after Jefferies upgraded the drugmaker to Buy from Hold driven by its ramp-up of key US generics products Advair and Vascepa and the ongoing success of the injectable medicines offering.

At the other end of the large-caps, BP ended 1.9% lower after Morgan Stanley downgraded the oil major to Underweight from Equal Weight.

Meanwhile, Deliveroo made its stock market debut on Wednesday in the most high-profile initial public offering in a decade.

American Will Shu founded the company in 2013 and made Deliveroo's first delivery in London. Shu got the idea to start his own business after struggling to find restaurants that would deliver food to the London office where he often stayed late to work as a financial analyst.

As well as being based in the UK and Ireland, Deliveroo is present in Australia, Belgium, France, Hong Kong, Kuwait, the Netherlands, Singapore, Spain and the United Arab Emirates.

Deliveroo and its rivals have enjoyed soaring sales during the coronavirus pandemic as lockdowns triggered surging demand for takeaway food.

However, its shares quickly tumbled in initial trading as investors question Deliveroo's treatment of its self-employed riders, questions over its business model and how much control Shu has over the company.

In the run up to the listing, prominent fund managers Aberdeen Standard and Legal & General said they would not be investing in Deliveroo amid concerns over employment rights and the dual-class share structure.

The share structure sees founder Shu have 20 votes per share, compared with one per share for other investors, giving him a majority position at shareholder votes.

The Amazon-backed company priced its IPO at 390 pence, giving it a valuation of GBP7.59 billion on admission. However, Class 'A' shares in Deliveroo closed at 287.45p, down 26% from the listing price.

"Deliveroo has gone from hero to zero as the much-hyped stock market debut falls flat on its face. It had better get used to the nickname 'Flopperoo'," commented AJ Bell's Russ Mould. "Sadly, the narrative took a turn for the worst when multiple fund managers came out and said they wouldn't back the business due to concerns about working practices. This is likely to have spooked a lot of people who applied for shares in the IPO offer, meaning they are racing to dump them."

The pound was quoted at USD1.3785 at the London equities close, rising from USD1.3722 at the close Tuesday, as investors took heart from the latest UK economic growth figures, with restrictions starting to ease.

The UK's economic slump for 2020 was revised to 9.8% from a first estimate of 9.9%, according to figures from the Office for National Statistics on Wednesday, though this is still the largest annual fall in the country's output on record.

The ONS made larger revisions to quarterly growth numbers.

Gross domestic product is estimated to have risen 1.3% quarter-on-quarter in the final three months of 2020, revised up from 1.0%. Year-on-year, the decline was 7.3%, also improved on revision from 7.8%.

The euro stood at USD1.1742 at the European equities close, higher from USD1.1730 late Tuesday, following inflation figures from the eurozone.

Eurozone consumer prices grew as expected in March, according to preliminary figures from Eurostat on Wednesday, though core inflation slowed.

Eurostat's flash estimate showed annual inflation quickened to 1.3% in March, from 0.9% in February. The figure was in-line with consensus cited by FXStreet.

Core inflation, which excludes food, energy, alcohol and tobacco, slowed to 0.9% according to the Eurostat estimate, from 1.1% in February. The flash figure was below consensus estimates for a 1.2% uptick.

Against the yen, the dollar was trading at JPY110.50, up from JPY110.27 late Tuesday.

Stocks in New York were higher at the London equities close following strong employment data as markets awaited the official unveiling of President Joe Biden's infrastructure plan.

The DJIA was up 0.1%, the S&P 500 index up 0.6% and the Nasdaq Composite up 1.7%.

Data from payroll services firm ADP showed private US employment jumped by 517,000 in March, slightly less than economists had expected but much better than the 176,000 gain in February and a welcome rebound after several tepid results in the pandemic recovery.

Meanwhile, investors were assessing early reports on Biden's USD2 trillion infrastructure plan, due to be released in Pittsburgh, Pennsylvania later in the day.

The plan includes some USD620 billion in transport, with Biden targeting a hike in the corporate tax rate to finance the spending.

"The big risk tonight is not that [Biden's] list disappoints, but that the market doesn't like the methods used to pay for the package. For now they seem unperturbed by potential rises in corporate taxes, perhaps reasoning that this is a small price to pay if economic growth rebounds and profit margins remain strong," IG Group's Chris Beauchamp said. "A solid ADP report helped to firm up risk appetite as well, providing further evidence of the rebound in the US economy and putting investors on watch for a similarly strong NFP reading on Friday."

Brent oil was quoted at USD64.00 a barrel at the equities close, lower against USD64.21 at the close Tuesday.

Gold was quoted at USD1,704.21 an ounce at the London equities close, higher from USD1,685.50 late Tuesday.

The economic events calendar on Thursday has manufacturing PMI readings from Germany, the eurozone, the UK and US at 0855 BST, 0900 BST, 0930 BST and 1445 BST respectively. In the afternoon, the latest jobless claims figures are due at 1330 BST.

The UK corporate calendar on Thursday has annual results from clothing and homewares retailer Next, financial services administration outsourcer Equiniti Group and online gambling company Sportech.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more
20 Apr 2022 09:16

IN BRIEF: Hikma gets preliminary US approval for Custopharm acquisition

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Receives preliminary approval from the US Federal Trade Commission for its planned acquisition of Custopharm Inc. Back in September, Hikma agreed to buy the California, US-based generic injectable products company for a total of up to USD425 million.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.